Mass spectrometry is the new genomics, and Tucson is the place to be for the emerging market. At least that’s what Nina Ossanna, vice president and co-founder of Pharos Diagnostics, thinks. Ossanna is ...
(MENAFN- GlobeNewsWire - Nasdaq) The North America Mass Spectrometry Market is poised to surge from US$ 2.6 Billion in 2024 to US$ 4.87 Billion by 2033, driven by a 7.21% CAGR. Key growth areas ...
In a recent study posted to the Preprints with The Lancet SSRN* server, a team of researchers in China developed a machine learning-based diagnostic tool to detect tuberculosis and drug-resistant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results